Re: Muayad et al.: Comparative effects of GLP-1 receptor agonists and metformin on glaucoma risk in patients with type 2 diabetes (Ophthalmology. 2024 Aug 23:S0161-6420(24)00515-3)
Ophthalmology. 2024 Dec 21:S0161-6420(24)00743-7.
doi: 10.1016/j.ophtha.2024.11.018.
Online ahead of print.
1 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
2 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Optometry, Shu-Zen Junior Colleage of Medicine and Management, Kaohsing, Taiwan.
3 Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Department of Allergy, Immunology & Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan; Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan. Electronic address: jccwei@gmail.com.